tiprankstipranks
Essex Bio-Technology Launches New Eye Drops in China
Company Announcements

Essex Bio-Technology Launches New Eye Drops in China

Essex Bio-Technology (HK:1061) has released an update.

Don't Miss Our Christmas Offers:

Essex Bio-Technology Limited has announced that its subsidiary, Zhuhai Essex Bio-Pharmaceutical Company Limited, has gained approval from China’s National Medical Products Administration to commercialize a new preservative-free unit-dose Diquafosol Sodium Eye Drop for treating dry eye syndromes. This product adds to the company’s existing portfolio of preservative-free eye treatments, indicating a potential expansion in the PRC’s healthcare market.

For further insights into HK:1061 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App